NIAID has placed a high priority on the development of safe and effective HIV vaccines for worldwide evaluation and use. A Preclinical Master Contract has been put in place to aid the preclinical development of promising vaccine candidates from the research laboratory to the clinic. This contract offers an array of resources to facilitate development of a promising candidate into a testable product. Resources are available to accomplish three basic functions:
Specific vaccines to be produced may include concepts proposed by either industry or academic institutions. Investigators wishing to access these services may submit proposals following the guidelines found on the DAIDS Guidelines for Requesting Access to Animal Models, Vaccine Reagents and Vaccine Development Resources.
Notable accomplishments to date from this contract are:
Michael Pensiero, Ph.D.
Division of AIDS, Preclinical Research and Development Branch
Last Updated December 01, 2009